Tibet Rhodiola Pharmaceutical Holding Co.,Ltd.’s Net Profit Rose 93.2% in First Three Quarters of 2023

Tibet Rhodiola Pharmaceutical Holding Co.,Ltd. (西藏诺迪康药业股份有限公司) (600211.SH) reported a net profit of 863.5 million yuan in the first three quarters of 2023, up 93.2% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 20.9% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 27%.